既往照射对放疗相关乳腺癌模型微环境的影响及免疫检查点抑制敏感性
研究通过将既往暴露于辐射的p53突变乳腺HC11上皮细胞移植至既往照射的乳腺脂肪垫,建立小鼠放疗相关乳腺癌模型。结果显示辐照基质中肿瘤发生率增加2倍,肿瘤及CD8+ T细胞TGFβ升高、CD4+ T细胞PD-L1升高,对免疫检查点抑制反应改善。提示既往照射通过肿瘤细胞自主与非自主机制促进肿瘤发生与免疫逃逸,放疗相关癌症可能对免疫检查点抑制更敏感。
要点
- 既往照射的乳腺脂肪垫使辐射暴露HC11细胞肿瘤发生率增加2倍
- 辐照基质来源肿瘤中TGFβ在肿瘤与CD8+ T细胞升高,PD-L1在CD4+ T细胞升高
- 辐照基质来源肿瘤对免疫检查点抑制反应改善
核心结论
- 既往照射通过肿瘤细胞自主和非自主机制促进肿瘤发生与免疫逃逸,放疗相关癌症可能比同组织学非放疗相关肿瘤对免疫检查点抑制反应更好。
研究设计与样本
- 研究建立小鼠放疗相关乳腺癌模型,将既往暴露于辐射的p53突变乳腺HC11上皮细胞移植至既往照射的乳腺脂肪垫。
主要发现
- 既往暴露辐射的HC11上皮细胞在照射乳腺脂肪垫中生长时肿瘤发生率增加2倍。
- 与假照射乳腺脂肪垫来源肿瘤相比,照射乳腺脂肪垫来源肿瘤的肿瘤细胞与CD8+ T细胞TGFβ升高,CD4+ T细胞PD-L1升高。
- 上述改变导致对免疫检查点抑制的反应改善。
临床怎么用
- 放疗相关乳腺癌模型提示既往照射可能增强免疫检查点抑制疗效,支持对该类患者评估免疫治疗敏感性。
局限性
- 原文未报告研究局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Radiation therapy confers a later risk of secondary malignancies, including radiation-associated breast cancer. Distinctive molecular profiles emerge in tumors from preirradiated tumor beds, but effects on the therapeutic options remain understudied. METHODS AND MATERIALS: We developed a murine model of radiation-associated breast cancer by transplanting p53-mutant mammary HC11 epithelial cells that had been previously exposed to radiation into mammary fat pads (MFP) that had been previously irradiated. RESULTS: Tumor incidence from HC11 epithelial cells that had been previously exposed to radiation increased 2-fold when grown in irradiated MFP. Compared with tumors grown in sham-irradiated MFP, tumors from irradiated MFP had elevated TGFβ in both tumor and CD8+ T cells and elevated PD-L1 on CD4+ T cells, resulting in improved response to immune checkpoint inhibition. CONCLUSIONS: This study provides evidence that prior irradiation potentiates tumorigenesis and immune evasion through both tumor cell autonomous and nonautonomous mechanisms. As a result, radiation-associated cancers may exhibit greater response to immune checkpoint inhibition than tumors of the same histology that are not associated with prior radiation therapy.
引用
- Rahman MM, Berg TJ, Allawi RH, et al. Effects of Prior Irradiation on the Microenvironment of a Radiation-Associated Breast Cancer Model Increase Sensitivity to Immune Checkpoint Inhibition. Int J Radiat Oncol Biol Phys. 2026. PMID: 42874813. doi:10.1016/j.ijrobp.2026.09.023
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。